Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 40
Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 121
Health Care M&A Deals, September 4, 2020
The Health Care M&A deals chart is a selection of transactions announced during the prior week(s). The M&A transactions presented here are from our Deal Search Online database, which is updated daily to provide our subscribers with the most up-to-date information and trends in the healthcare industry. The largest deal of the week is Nestle Health Science’s acquisition of Aimmune Therapeutics, Inc. for $2.6 billion. Nestle Health Science is acquiring Aimmune Therapeutics through its wholly-owned subsidiary, Societe des Produits Nestle S.A. The acquisition is an extension of Nestle Health Science’s food allergy portfolio, creating a broader spectrum of... Read More »
Triage Medical Staffing and TaleMed Merge
A pair of the nation’s largest healthcare staffing firms are merging. Ohama, Nebraska-based Triage Medical Staffing is acquiring TaleMed, LLC, creating one of the nation’s largest dual-threat Nursing and Allied Health recruitment agencies. No terms were disclosed, but the combined company is expected to have $200 million in annual revenues. TaleMed provides contingent staffing solutions to healthcare systems and hospitals nationwide through direct contract relationships and is consistently rated as one of the top travel healthcare companies. The company is also a top-tier provider with many prominent managed service providers. In recent years, Triage has experienced accelerated... Read More »
New Physician Medical Group Acquisitions in August
There was an eclectic mix of Physician Medical Group acquisitions in August, with nine on the books so far, according to Deal Search Online. Good news has remained rare for the sector during the COVID-19 pandemic, but investors are keeping up with dealmaking nonetheless. Here a few notable deals. Vancouver-based CRH Medical Corporation (NYSE: CRHM) continued its buying spree, acquiring Orange County Anesthesia Associates, LLC for $6.2 million. Orange County Anesthesia provides anesthesia services to a single gastroenterology ambulatory surgery center in Orlando, Florida, and generates annual revenues of $3.1 million. Orange County Anesthesia is CRH Medical’s fifth physician medical... Read More »
Sonde Health Buys NeurLex to Boost Voice Science Platform
Last week, Boston-based Sonde Health acquired NeuroLex Laboratories, Inc. to expand its voice-based technology platform. Sonde’s proprietary platform detects symptoms of health conditions, such as depression and respiratory disease, from changes in voice. Using machine learning, Sonde senses and analyzes subtle vocal changes due to changes in a person’s physiology to provide early health detection and monitoring. Sone Health has 300,000 voice samples from over 50,000 individuals. The data is especially useful in the fields of psychosis and related psychiatric treatment. NeuroLex Labs offers highly complementary services. It also uses speech analysis to detect various health... Read More »
CloudMD Adds Behavioral Health Clinic Network
CloudMD Software & Services Inc. (OTCMKTS: DOCRF) has spent most of 2020 expanding its physical presence throughout North America, reaching into new markets. Last week, the company acquired Re:Function Health Group Inc., a leading rehabilitation clinic network, with 7 clinics and 35 behavioral health specialists and allied health professionals across British Columbia. CloudMD will pay $3.4 million through a mix of cash and shares, and a potential $1.15 million in performance-based earnouts. Re:Function Health generated $4.38 million in revenue in 2019. This acquisition represents a significant addition to the depth and spectrum of healthcare services provided by the CloudMD platform.... Read More »
Nestle Health Science Strikes New Multibillion Deal
Nestle Health Science, a global business unit of Nestle S.A. (SWX: NESN), has announced a takeover of California-based Aimmune Therapeutics, Inc. (NASDAQ: AIMT) valued at $2.6 billion. Aimmune Therapeutics is a biopharmaceutical company developing and commercializing oral treatments for potentially life-threatening food allergies. Nestle Health Science previously had a total investment in Aimmune of $473 million, an approximate 25.6% equity ownership stake, and will pay $34.50 per share in cash for the remainder, or a 174% premium to Aimmune’s closing share price on August 28 of $12.60. Aimmune reported a trailing 12-month revenue of $575,000. Nestle Health Science is acquiring... Read More »
Health Care M&A Deals, August 28, 2020
The Health Care M&A deals chart is a selection of transactions announced during the prior week(s). The M&A transactions presented here are from our Deal Search Online database, which is updated daily to provide our subscribers with the most up-to-date information and trends in the healthcare industry. The largest deal of the week is Royal Philips’ acquisition of Intact Vascular, Inc. for $360 million. Intact Vascular will enhance Philips’ image-guided therapy portfolio, combining Philips’ interventional imaging platform and diagnostic and therapeutic devices with Intact Vascular’s unique, specialized implantable device to optimize the treatment of patients with Peripheral... Read More »
QIAGEN Pushes On After Thermo Fisher Walks Away
In early March, Thermo Fisher Scientific Inc. (NYSE: TMO) announced a takeover QIAGEN N.V. (NYSE: QGEN) for $11.5 billion, or $43.64 per share in cash. The offer seemed high enough, as the target company only generated revenues of $1.53 billion in 2019, but the COVID-19 pandemic complicated the deal. QIAGEN saw a surge in product demand used in COVID-19 testing, as net sales grew 16% in Q2:20 over the same quarter in 2019, so its shareholders thought Thermo Fisher’s needed to up its offer. Thermo Fisher revised its offer to $49 per share on August 4, but it needed a minimum acceptance threshold of 66.67% from QIAGEN shareholders before the August 10 deadline. The new acquisition... Read More »
Vocera Adds New Patient Engagement Firm
Vocera Communications, Inc. (NYSE: VCRA), a mobile technology company serving the healthcare market, has expanded its patient engagement platform through a new acquisition. Last week, Vocera purchased a 100% interest in EASE Applications, LLC for $25 million in cash. This is Vocera’s first acquisition of 2020, but the company has had a solid financial year, reporting total revenue of $47.3 million for the second quarter of 2020, compared to revenue of $44.8 million in the second quarter of 2019. Its remote communication services were probably in high demand due to changes triggered by COVID-19. The addition of EASE will most likely help them in the COVID-19 environment as well. EASE... Read More »Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
